About the Authors
- Nikunj Satani
-
Affiliations Department of Neurology, McGovern Medical School, UTHealth, Houston, TX, United States of America, Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America
- Yu-Hsi Lin
-
Affiliation Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America
- Naima Hammoudi
-
Affiliation Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America
- Sudhir Raghavan
-
Affiliation Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America
- Dimitra K. Georgiou
-
Affiliation Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America
- Florian L. Muller
-
* E-mail: fmuller@mdanderson.org
Affiliation Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America
Competing Interests
N.S., Y.H.L. and F.L.M. are inventors on a patent application concerning SF2312 and its derivatives as inhibitors of Enolase.
Author Contributions
Conceptualization: FLM NS. Data curation: NS. Formal analysis: NS YHL SR. Funding acquisition: FLM. Investigation: FLM NS. Methodology: FLM NS YHL NH SR. Project administration: FLM. Supervision: FLM. Validation: FLM NS NH YHL. Visualization: FLM NS. Writing – original draft: FLM NS. Writing – review & editing: NS DKG.